In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Logical Therapeutics brings in $10mm through its Series C round

Executive Summary

Logical Therapeutics Inc. (developing compounds for inflammatory conditions) has raised $10mm through its Series C venture round. SV Life Sciences led the financing and was joined by Burrill & Co., Novo AS, and Novitas Capital. According to its Form D filing, the company may bring in another $6.9mm before closing.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies